Citation Impact

Citing Papers

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution
2013
Glutathione S-transferase M1 and T1 genetic polymorphisms, alcohol consumption and breast cancer risk
2003
The glutathione peroxidases
2001 Standout
Myasthenia Gravis
2016 Standout
Multiple sclerosis: Genomic rewards
2001
Molecular dissection of reactive astrogliosis and glial scar formation
2009 Standout
The Glutathione Biotransformation System and Colorectal Cancer Risk in Humans
2001
Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines
2007
Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits
2017 StandoutNobel
SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis
2000 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Advances in metal-induced oxidative stress and human disease
2011 Standout
Cochrane reviews of educational and self-management interventions to guide nursing practice: A review
2008 Standout
Acute promyelocytic leukemia: what are the treatment options?
2010
The Clinical Epidemiology of Multiple Sclerosis
2008
Polymorphisms of N-Acetyltransferases, Glutathione S-Transferases, Microsomal Epoxide Hydrolase and Sulfotransferases: Influence on Cancer Susceptibility
1998
Alcohol and public health
2005 Standout
A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology
2012
Role of glutathione S-transferase Mu-1 (GSTM1) polymorphism in oligospermic infertile males
2010
Pediatric Multiple Sclerosis
2011
Anti–Aquaporin‐4 monoclonal antibody blocker therapy for neuromyelitis optica
2011
No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: A meta-analysis from 5472 cases and 4727 controls
2011
Chronic graft-versus-host disease
2003 Standout
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
2002 Standout
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
Association of the glutathione S-transferase M1 homozygous null genotype with susceptibility to Sj�gren's syndrome in Japanese individuals
1999 StandoutNobel
Immunopathology of multiple sclerosis
2015 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Genetic determinants of hair color and parkinson's disease risk
2009
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Gene variants for osteoporosis and their pleiotropic effects in aging
2005
Genetics of primary progressive multiple sclerosis
2014
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice
2009 StandoutNobel
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
Genetic factors influencing the development of chronic graft-versus-host disease in a murine model
2000
Periodontal diseases
2017 Standout
Neuromyelitis optica spectrum disorders associated with other autoimmune diseases
2014
Immunoadsorption in neurological disorders
2017
Genetic Polymorphisms in Human Drug-Metabolizing Enzymes: Potential Uses of Reverse Genetics to Identify Genes of Toxicological Relevance
1997
The Molecular Epidemiology of Lung Cancer
1997
An automated tool for detection of FLAIR-hyperintense white-matter lesions in Multiple Sclerosis
2011 Standout
Modulation of Clinical Expression of Plaque‐Induced Gingivitis: Interleukin‐1 Gene Cluster Polymorphisms
2005
Invited Commentary Potential Contribution of the Glutathione S-Transferase Supergene Family to Resistance to Oxidative Stress
1995
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders
2015
Interleukin-10 promoter polymorphisms in patients with Guillain–Barré syndrome
2003
GSTM1, GSTT1, GSTP1, GSTA1 and colorectal cancer risk: A comprehensive meta-analysis
2010 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Clinical Efficacy of Plasmapheresis in Patients with Neuromyelitis Optica Spectrum Disorder and Effects on Circulating Anti-Aquaporin-4 Antibody Levels
2013
A population-based study of neuromyelitis optica in Caucasians
2011
Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression
2007 StandoutNobel
Blood—Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability
2012
Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity
2003
Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder
2009
Information provision for people with multiple sclerosis
2014
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Vitamin D and Immune Function
2013 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries
2022 Standout
Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic Leukemia
1997
Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women
2008
Plasma Exchange in Severe Attacks of Neuromyelitis Optica
2012

Works of M. Boggild being referenced

Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis
1999
The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas
1993
EFNS guidelines on diagnosis and management of neuromyelitis optica
2010
Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity
2002
HLA-DRB1 and disease outcome in multiple sclerosis
2001
Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis
2000
A randomized controlled trial of a health promotion education programme for people with multiple sclerosis
2006
Glutathione S-transferase polymorphisms in MS
2000
Susceptibility and outcome in MS
2004
A window of opportunity for no treatment in early multiple sclerosis?
2010
Studies of associations between disability in multiple sclerosis, skin type, gender and ultraviolet radiation
2007
Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure
1989
Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
2009
Rankless by CCL
2026